|
2024-04-10 |
2024-04-08 |
A
Achat
|
Wills Robert James
Administrateur non-exécutif
|
3 086
+44.6%
8,96
27 655 USD
|
3 086
+44.6%
|
8,96
|
27 655 USD
|
|
|
2024-04-01 |
2024-03-28 |
A
Achat
|
Wills Robert James
Administrateur non-exécutif
|
6 914
+inf%
8,48
58 602 USD
|
6 914
+inf%
|
8,48
|
58 602 USD
|
|
|
2024-02-27 |
2024-02-23 |
V
Vente
|
Wills Robert James
Administrateur non-exécutif
|
980
-100.0%
9,04
8 859 USD
|
980
-100.0%
|
9,04
|
8 859 USD
|
|
|
2024-02-27 |
2024-02-23 |
A
Achat
|
HALE DAVID F
Administrateur non-exécutif
|
266
+0.9%
9,04
2 405 USD
|
266
+0.9%
|
9,04
|
2 405 USD
|
|
|
2024-02-27 |
2024-02-23 |
A
Achat
|
HALE DAVID F
Administrateur non-exécutif
|
714
+inf%
9,04
6 455 USD
|
714
+inf%
|
9,04
|
6 455 USD
|
|
|
2023-06-14 |
2023-06-14 |
A
Achat
|
Kaufmann Gunnar F.
Chief Scientific Officer
Dirigeant
|
3 000
+3.3%
0,36
1 079 USD
|
3 000
+3.3%
|
0,36
|
1 079 USD
|
|
|
2023-06-14 |
2023-06-12 |
A
Achat
|
Kaufmann Gunnar F.
Chief Scientific Officer
Dirigeant
|
25 000
+37.5%
0,35
8 745 USD
|
25 000
+37.5%
|
0,35
|
8 745 USD
|
|
|
2023-04-17 |
2023-04-14 |
A
Achat
|
BREITMEYER JAMES B
Chief Executive Officer
Administrateur exécutif
|
2 250
+1.2%
0,29
653 USD
|
2 250
+1.2%
|
0,29
|
653 USD
|
|
|
2023-04-17 |
2023-04-14 |
A
Achat
|
BREITMEYER JAMES B
Chief Executive Officer
Administrateur exécutif
|
47 750
+32.6%
0,30
14 277 USD
|
47 750
+32.6%
|
0,30
|
14 277 USD
|
|
|
2023-04-14 |
2023-04-14 |
A
Achat
|
Yazji Salim
Chief Medical Officer
Dirigeant
|
5 000
+3.1%
0,30
1 500 USD
|
5 000
+3.1%
|
0,30
|
1 500 USD
|
|
|
2023-04-17 |
2023-04-13 |
A
Achat
|
BREITMEYER JAMES B
Chief Executive Officer
Administrateur exécutif
|
100 000
+214.9%
0,29
29 000 USD
|
100 000
+214.9%
|
0,29
|
29 000 USD
|
|
|
2023-04-14 |
2023-04-13 |
A
Achat
|
VINCENT RICHARD G
Chief Financial Officer
Dirigeant
|
30 000
+23.6%
0,30
8 961 USD
|
30 000
+23.6%
|
0,30
|
8 961 USD
|
|
|
2023-04-14 |
2023-04-13 |
A
Achat
|
Yazji Salim
Chief Medical Officer
Dirigeant
|
10 000
+6.7%
0,29
2 850 USD
|
10 000
+6.7%
|
0,29
|
2 850 USD
|
|
|
2023-04-14 |
2023-04-13 |
A
Achat
|
Leavitt Chase C.
General Counsel/Secretary
Dirigeant
|
10 000
+10.3%
0,29
2 900 USD
|
10 000
+10.3%
|
0,29
|
2 900 USD
|
|
|
2023-04-14 |
2023-04-12 |
A
Achat
|
Yazji Salim
Chief Medical Officer
Dirigeant
|
10 000
+7.2%
0,29
2 850 USD
|
10 000
+7.2%
|
0,29
|
2 850 USD
|
|
|
2023-04-14 |
2023-04-12 |
A
Achat
|
Leavitt Chase C.
General Counsel/Secretary
Dirigeant
|
15 000
+18.3%
0,29
4 350 USD
|
15 000
+18.3%
|
0,29
|
4 350 USD
|
|
|
2022-03-28 |
2022-03-28 |
A
Achat
|
VINCENT RICHARD G
Chief Financial Officer
Dirigeant
|
2 500
+2.9%
1,40
3 500 USD
|
2 500
+2.9%
|
1,40
|
3 500 USD
|
|
|
2022-03-28 |
2022-03-25 |
A
Achat
|
VINCENT RICHARD G
Chief Financial Officer
Dirigeant
|
2 136
+2.6%
1,49
3 182 USD
|
2 136
+2.6%
|
1,49
|
3 182 USD
|
|
|
2022-03-28 |
2022-03-25 |
A
Achat
|
VINCENT RICHARD G
Chief Financial Officer
Dirigeant
|
5
+0.0%
1,48
7 USD
|
5
+0.0%
|
1,48
|
7 USD
|
|
|
2022-03-28 |
2022-03-25 |
A
Achat
|
VINCENT RICHARD G
Chief Financial Officer
Dirigeant
|
356
+0.4%
1,45
516 USD
|
356
+0.4%
|
1,45
|
516 USD
|
|
